ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

China's 'fire extinguisher' fight against deadly new COVID wave

Universal testing seen by some experts as best approach; others disapprove

People in face masks attend a flag-raising ceremony in Tiananmen Square on National Day in Beijing on Oct. 1.    © Reuters

Eleven months after the first case of COVID-19 appeared in the central Chinese city of Wuhan, the world outside China continues racking up infections in an alarming rate. The approaching flu season is adding to the pressure on already strained medical systems.

In China, the coronavirus has been largely contained. But to block its return from abroad, the nation is taking unprecedented and controversial measures to build up medical capacity, track down every imported case and conduct mass testing in cities where sporadic new cases are found.

The U.S. reported nearly 100,000 new cases in a single day on Friday, bring its total caseload to more than 9 million, according to Johns Hopkins University. In Europe, record numbers of new infections have forced countries including the U.K., France, Germany, and Belgium to impose renewed nationwide lockdowns. In China, new clusters of domestic cases were found in Qingdao and Kashgar, raising alarms among experts that the fight against the pandemic may not end soon.

"We must know that no place in the world can be secluded from the rest of the world," said Shanghai's top infectious diseases expert, Zhang Wenhong. "As long as the global pandemic is not over, the epidemic in China will not be completely solved." In April, Zhang predicted a second wave of the COVID-19 pandemic worldwide is likely to occur after the fall.

Second wave worse than first

As people become increasingly fatigued with mask-wearing, social distancing and hand hygiene after months of vigilance, many authorities say they expect the second wave to be worse than the first in the spring. That's partly because the arrival of the winter influenza season means more people are likely to be infected with both the flu and COVID-19.

French President Emmanuel Macron said 400,000 people will die of coronavirus if the country does nothing to control a second wave that will be "more deadly than the first." The U.S. Centers for Disease Control and Prevention now projects there will be as many as 240,000 coronavirus deaths in the U.S. by Nov. 7.

As the number of cases abroad rises, so does the risk facing China.

"Once an imported case slips into China, local outbreaks are likely to occur," said Pan Pinhua, a professor and vice chairman of respiratory and critical care medicine of the Xiangya Hospital of Central South University, in the central Chinese city of Changsha.

Part of the challenge for China is that the nation has just four intensive care unit beds per 100,000 population. In the U.S., the figure was 34.2 in 2015, according to a paper published by the National Center for Biotechnology Information. Germany has 29.2, according to a paper published in the Intensive Care Medicine journal, based on 2012 data. To avoid a squeeze on medical resources, countries with low per capita medical resources, such as China, must adopt a strict prevention and control strategy at the early stage of an epidemic, according to some studies.

Data has shown that low temperatures are often conducive to virus survival and transmission, which is why viral pneumonia and other respiratory infections usually peak in winter.

"Increased indoor activities in winter, closer human contact and worse ventilation, with closed windows, all create conditions for the spread of the virus," said Jiang Qingwu, an epidemiologist and former dean of the School of Public Health at Fudan University.

Unlike other respiratory viruses such as influenza that spread mainly in the winter, the COVID-19 pathogen has demonstrated no seasonal pattern, according to experts, including the emergencies chief for the World Health Organization.

Double hit

More experts are now warning of a potentially deadly combination of COVID-19 and the flu. Both are contagious respiratory illnesses and share similar symptoms, such as fever, cough, body aches, and sometimes vomiting and diarrhea. A double hit not only would mean more testing of patients with fever but also would make it harder to distinguish COVID-19 from flu, delaying treatment and quarantines.

In late January, a patient in Beijing was admitted to a hospital for severe flu after testing negative three times for COVID-19. Only after he was put on a ventilator was the patient found to be positive for COVID-19 in a bronchoalveolar lavage test, in which a bronchoscope is passed through the mouth or nose to collect fluid from the lower respiratory system. This was considered a typical case that was initially diagnosed as flu but actually involved infection with both viruses.

The combination of COVID-19 and the flu could lead to hospitals being stretched to capacity. The WHO estimates that 1 billion people worldwide get the flu every year. In the U.S., the CDC estimates that there were 39 million to 56 million cases of flu between Oct. 1, 2019, and April, 4 this year.

China reported 3.54 million flu cases in 2019, with only 269 deaths, a figure that scientists have long believe was understated, as deaths from pneumonia caused by the flu are not included in the number. An analysis by Chinese scientists published in the medical journal Lancet Public Health in September 2019 found that there were 84,200 to 92,000 flu-related deaths in China each year.

Studies have shown that combined infections of influenza and COVID-19 result in more severe symptoms and a longer period of illness. In a study funded by the Italian Ministry of Health, the Rome Municipal Hospital for Infectious Diseases found that in 37 cases of COVID-19 and flu co-infection, all showed similar clinical symptoms such as fever, cough and shortness of breath. Nine cases, or about a quarter, presented acute respiratory distress syndrome with progressive deterioration. Six patients required intensive care but recovered, while three died.

The second wave of the pandemic is already pushing Europe into a medical crisis, with intensive care units quickly filling to the breaking point. France's Macron warned that "at this stage, we know that whatever we do, nearly 9,000 patients will be in intensive care by mid-November, which is almost the entirety of French capacity." Belgium, which has doubled its intensive care capacity, is working on deciding which needy patients should get a bed.

China braces itself

China has been preparing since summer for a second wave this winter. In Wuhan, the epicenter of China's first outbreak, four makeshift hospitals that were set up in February in converted gyms and convention and exhibition centers to isolate and treat mild cases, remain on standby. Once a second outbreak occurs, each hospital can serve as many as 700 patients, said Ling Ruijie, vice president of Hubei Provincial Hospital of Integrated Chinese and Western Medicine, who is in charge of one of the makeshift hospitals.

Hospitals across China have taken measures to revamp their fever clinics, build quarantine shelters and infectious disease hospitals, and stock medical supplies.

In Yunnan Province, in southwestern China, which borders Myanmar and faces higher risks of imported cases, the government plans to build 16 city-level infectious disease hospitals and six hospitals in the border counties. The government in Guangxi, bordering Vietnam, invested 500 million yuan ($74.7 million) on hospital renovation and expansion.

But capacity-building doesn't happen overnight, Shanghai expert Zhang Wenhong cautioned.

"Not every city is like Shanghai," Zhang said. "If there is an outbreak, the medical system will surely be under pressure."

Fire extinguisher approach

This is what China has been doing after learning a hard lesson in Wuhan. In September, Ruili, a border city in Yunnan, enacted a one-week lockdown and tested all 200,000 residents for the coronavirus after two people who illegally entered the city from Myanmar were found to have COVID-19.

Last month, Qingdao became the site of China's first domestic COVID-19 outbreak in several months. After a dozen cases were found to be associated with a hospital, the eastern port city tested its entire 9.4 million residents in just five days.

In the latest domestic outbreak in far western China, the prefecture of Kashgar commenced mass testing of its entire population of 4.75 million.

In Europe, Slovakia became the first country of its size to conduct nationwide testing of 5.4 million people.

The aggressive testing seems to have worked in China. All the new clusters have been locally contained. By identifying asymptomatic cases and moving to block early transmission, the mass testing is the best take-no-risk approach, said Pan from Xiangya Hospital of Central South University.

But some argue that this approach costs too much and wastes medical resources. Wang Guangfa, a respiratory specialist from Peking University First Hospital in Beijing who was infected with COVID-19 in January during his visit to Wuhan and later recovered, said he disapproves of indiscriminate mass testing. Wuhan's testing of its nearly 10 million people aimed to tell the world the city was safe, more than to identify asymptomatic cases, Wang said.

China aims to take every necessary measure to return to zero COVID-19 cases, a strategy Feng Zijian, vice director of China's Centers for Disease Control and Prevention, calls a "fire extinguisher" approach. Ultimately, ending the pandemic will depend on vaccines, Feng said.

China is expanding the number of people receiving experimental COVID-19 vaccines. Two eastern cities are offering one to the general public, and a biotech company is providing another one free to students heading abroad, even as clinical trials are still underway to determine their safety and effectiveness.


Read also the original story. is the English-language online news portal of Chinese financial and business news media group Caixin. Nikkei recently agreed with the company to exchange articles in English.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more